{"id":"W3110512790","doi":"10.1016/j.jaad.2020.06.154","title":"14027 Long-term efficacy and safety of continuous q12w risankizumab: Results from the open-label extension LIMMitless trial","year":2020,"lang":"en","type":"article","venue":"Journal of the American Academy of Dermatology","topic":"Monoclonal and Polyclonal Antibodies Research","field":"Medicine","cited_by":2,"is_retracted":false,"has_abstract":false,"ca_institutions":"Probity Medical Research","funders":"","keywords":"Medicine; Ustekinumab; Open label; Monoclonal; Monoclonal antibody; Internal medicine; Clinical trial; Adalimumab; Immunology; Antibody; Disease","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002032098,0.000946272,0.002240569,0.0002116869,0.0003133678,0.001341851,0.0007728633,0.00129329,0.005486071],"category_scores_gemma":[0.002018005,0.0003390782,0.002590769,0.0003350255,0.001259319,0.001174079,0.0003734448,0.00360905,0.001882189],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009403626,"about_ca_system_score_gemma":0.001000798,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0006042223,"about_ca_topic_score_gemma":0.0009079808,"domain_scores_codex":[0.9989055,0.0004934385,0.00005737703,0.0002036339,0.0001393939,0.0002005738],"domain_scores_gemma":[0.9986283,0.0005032163,0.0002861967,0.0001925798,0.000104137,0.0002855877],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"nonrandomized_trial","study_design_scores_codex":[0.8871086,0.004434111,0.002521053,0.001182675,0.002341565,0.00009058102,0.00008596321,0.0007510064,0.007423568,0.0004081187,0.005740465,0.08791232],"study_design_scores_gemma":[0.8207318,0.1458089,0.02007917,0.0001960104,0.0026298,0.0001968559,0.00008732803,0.001268081,0.002314648,0.0007383444,0.005881169,0.00006784491],"study_design_candidate":"nonrandomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9757652,0.01188997,0.000959624,0.001235652,0.0004489358,0.0006900054,0.00359353,0.0002119313,0.005205229],"genre_scores_gemma":[0.9871637,0.002609606,0.0007714757,0.001357898,0.0004581659,0.000613354,0.003519299,0.0000438495,0.003462693],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.005486071,"threshold_uncertainty_score":0.01835275,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07985569615250328,"score_gpt":0.3830480991294195,"score_spread":0.3031924029769162,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}